You have 9 free searches left this month | for more free features.

Advanced Cancer

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 10, 2023

Solid Tumors Trial in France, United States (MEDI9253, Durvalumab)

Recruiting
  • Solid Tumors
  • MEDI9253
  • Durvalumab
  • La Jolla, California
  • +19 more
Jul 28, 2022

Differentiated Thyroid Cancer, Pediatric Cancer, Cancer Trial (Larotrectinib monotherapy, 131I therapy)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • +3 more
  • Larotrectinib monotherapy
  • 131I therapy
  • (no location specified)
Mar 13, 2023

Prostatic Tumors, Prostatic Tumors, Castration-Resistant Trial in New Orleans (68 Ga-PSMA-11 prepared using a PSMA-11 Sterile

Available
  • Prostatic Neoplasms
  • Prostatic Neoplasms, Castration-Resistant
  • 68 Ga-PSMA-11 prepared using a PSMA-11 Sterile Cold Kit
  • New Orleans, Louisiana
    Tulane Medical Center
Apr 25, 2022

Gastric Cancer, Cancer of the Stomach, Esophagogastric Junction Trial in Worldwide (BMS-986213, Nivolumab, XELOX)

Active, not recruiting
  • Gastric Cancer
  • +2 more
  • BMS-986213
  • +4 more
  • Clovis, California
  • +77 more
Jan 9, 2023

Melanoma Trial in Worldwide (Immunotherapeutic GSK2132231A)

Completed
  • Melanoma
  • Immunotherapeutic GSK2132231A
  • Los Angeles, California
  • +62 more
Dec 7, 2020

Cancer Trial in United States (WT2725)

Completed
  • Cancer
  • WT2725
  • Tucson, Arizona
  • +5 more
May 8, 2019

Acute Pain, Cancer Pain Trial in Santiago (Acetaminophen, Placebo)

Completed
  • Acute Pain
  • Cancer Pain
  • Santiago, Chile
    Universidad Catolica de Chile
Aug 12, 2021

Eosinophilic Esophagitis Trial in Worldwide (Etrasimod, Placebo)

Active, not recruiting
  • Eosinophilic Esophagitis
  • Birmingham, Alabama
  • +222 more
Dec 8, 2022

Breast Cancer, Estrogen Receptor Positive Tumor, HER2-positive Breast Cancer Trial in Worldwide (Paclitaxel, Trastuzumab,

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Brasschaat, Belgium
  • +53 more
Nov 29, 2022

Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, Malignant Tumor Trial in Los Angeles, Houston

Terminated
  • Adenocarcinoma of the Extrahepatic Bile Duct
  • +6 more
  • trastuzumab
  • laboratory biomarker analysis
  • Los Angeles, California
  • +1 more
Jul 29, 2019

Hepatocellular Carcinoma (HCC) Trial in China (Brivanib 800 mg, QD, Brivanib 400 mg, BID)

Completed
  • Hepatocellular Carcinoma (HCC)
  • Brivanib 800 mg, QD
  • Brivanib 400 mg, BID
  • Hefei, Anhui, China
  • +14 more
Sep 3, 2019

Melanoma Trial in Sydney, Wollstonecraft, Melbourne (Dabrafenib, Trametinib, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • Sydney, New South Wales, Australia
  • +2 more
Apr 4, 2022

Kidney Cancer Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (cell infusion)

Recruiting
  • Kidney Cancer
  • cell infusion
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 2, 2022

NSCLC Stage IV, EGFR Gene Mutation Trial in Worldwide (Osimertinib, Stereotactic Body Radiation Therapy (SBRT))

Recruiting
  • NSCLC Stage IV
  • EGFR Gene Mutation
  • Alessandria, Italy
  • +15 more
Mar 29, 2022

Ovarian Cancer, Ovarian Carcinoma, Stage II Ovary Cancer Trial in United States (Mind-body resilience training, Music therapy,

Recruiting
  • Ovarian Cancer
  • +13 more
  • Mind-body resilience training
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Jun 28, 2022

Thyroid Cancer Trial in Suita (Targeted alpha therapy)

Recruiting
  • Thyroid Cancer
  • Targeted alpha therapy
  • Suita, Japan
    Osaka University Hospital
Mar 2, 2022

Colorectal Cancer Metastatic Disease in Middle-Norway

Active, not recruiting
  • Neoplasms, Colorectal
  • Neoplasm Metastasis
  • cancer treatment and follow-up according to current regional and national guidelines
  • Kristiansund, Norway
  • +6 more
Feb 10, 2022

Cervical Cancer, Recurrent Cervical Cancer, Metastatic Cervical Cancer Trial in Mobile (Cabozantinib 40 MG oral once a day,

Terminated
  • Cervical Cancer
  • +3 more
  • Cabozantinib 40 MG oral once a day
  • Pembrolizumab 200 mg IV every 3 weeks
  • Mobile, Alabama
    University of South Alabama Mitchell Cancer Institute
Jun 3, 2022

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Springfield (Omega Nutrition cold-milled

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Omega Nutrition cold-milled flaxseeds
  • Springfield, Illinois
    Southern Illinois University School of Medicine
Mar 30, 2022

Glioblastoma Trial in Commack, Harrison, New York (Focus Group, Meaning-Centered Psychotherapy for Cancer Caregivers / MCP-C,

Active, not recruiting
  • Glioblastoma
  • Focus Group
  • +2 more
  • Commack, New York
  • +2 more
Nov 9, 2022

Ramucirumab and Paclitaxel in Gastric or Gastroesophageal

Completed
  • Gastric or Gastroesophageal Junction Adenocarcinoma
    • Ansan, Korea, Republic of
    • +56 more
    Mar 22, 2021

    Esophageal Squamous Cell Carcinoma (ESCC) Trial in Taiwan (BI-754091 plus afatinib)

    Enrolling by invitation
    • Esophageal Squamous Cell Carcinoma (ESCC)
    • BI-754091 plus afatinib
    • Kaohsiung, Taiwan
    • +4 more
    Aug 30, 2021

    Locally Advanced Malignant Tumor, Gastric Cancer Trial in Loma Linda (Hyperthermic Intraperitoneal Chemotherapy (HIPEC))

    Completed
    • Locally Advanced Malignant Neoplasm
    • Gastric Cancer
    • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    • Loma Linda, California
      Loma Linda University Cancer Center
    Apr 10, 2019

    Renal Cell Carcinoma Trial in Macquarie University, Haifa (Belzutifan, Palbociclib)

    Recruiting
    • Renal Cell Carcinoma
    • Macquarie University, New South Wales, Australia
    • +1 more
    Aug 15, 2022